沃华医药2025年业绩创新高，净利润增长162.93%

Group 1 - The core focus of the company is on four exclusive medical insurance products, with outpatient market revenue exceeding 100 million yuan and e-commerce channel sales increasing by 113% year-on-year [1] - The company reported an operating income of 817 million yuan for 2025, a year-on-year increase of 6.96%, and a net profit attributable to shareholders of 95.71 million yuan, a significant increase of 162.93%, marking a ten-year high [2] - The company plans to distribute a cash dividend of 1.46 yuan per 10 shares, totaling approximately 154 million yuan, reflecting a stable financial strategy [2] Group 2 - The stock price of the company has shown volatility over the past seven trading days, closing at 7.28 yuan on February 9, down 0.82%, with a net outflow of 5.228 million yuan in principal funds [3] - As of February 12, the latest stock price was 7.22 yuan, a decrease of 0.96% from the previous day, with a cumulative decline of 0.69% over five days [3] - Trading activity has decreased, with the turnover rate dropping from 3.07% on February 6 to 0.66% on February 12 [3]